These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11984384)

  • 21. The design and conduct of clinical trials to limit missing data.
    Little RJ; Cohen ML; Dickersin K; Emerson SS; Farrar JT; Neaton JD; Shih W; Siegel JP; Stern H
    Stat Med; 2012 Dec; 31(28):3433-43. PubMed ID: 22829439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 2: Randomized controlled trials.
    Manchikanti L; Hirsch JA; Smith HS
    Pain Physician; 2008; 11(6):717-73. PubMed ID: 19057624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How to Measure Motivational Interviewing Fidelity in Randomized Controlled Trials: Practical Recommendations.
    Jelsma JG; Mertens VC; Forsberg L; Forsberg L
    Contemp Clin Trials; 2015 Jul; 43():93-9. PubMed ID: 25962891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SPIRIT extension and elaboration for n-of-1 trials: SPENT 2019 checklist.
    Porcino AJ; Shamseer L; Chan AW; Kravitz RL; Orkin A; Punja S; Ravaud P; Schmid CH; Vohra S;
    BMJ; 2020 Feb; 368():m122. PubMed ID: 32107202
    [No Abstract]   [Full Text] [Related]  

  • 25. Adding more muscle and nerve to clinical trials.
    Conwit RA; Bhanushali MJ; Porter JD; Kaufmann P; Gutmann L
    Muscle Nerve; 2011 Nov; 44(5):695-702. PubMed ID: 22006684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized controlled trials: methodological concepts and critique.
    Salmond SS
    Orthop Nurs; 2008; 27(2):116-22; quiz 123-4. PubMed ID: 18385595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methodological advances and plans for improving regulatory success for confirmatory studies.
    Koch GG; Davis SM; Anderson RL
    Stat Med; 1998 Aug 15-30; 17(15-16):1675-90. PubMed ID: 9749439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. All that is measured may not help.
    Gross M
    Can J Surg; 2000 Dec; 43(6):406. PubMed ID: 11129824
    [No Abstract]   [Full Text] [Related]  

  • 29. Improving the quality of randomized controlled trials in Chinese herbal medicine, part I: clinical trial design and methodology.
    Bian ZX; Li YP; Moher D; Dagenais S; Liu L; Wu TX; Miao JX; Kwan AK; Song L
    Zhong Xi Yi Jie He Xue Bao; 2006 Mar; 4(2):120-9. PubMed ID: 16529686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perspective: US Documentation and Regulation of Human Nutrition Randomized Controlled Trials.
    Weaver CM; Fukagawa NK; Liska D; Mattes RD; Matuszek G; Nieves JW; Shapses SA; Snetselaar LG
    Adv Nutr; 2021 Feb; 12(1):21-45. PubMed ID: 33200185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The management of interim analyses in drug development.
    Facey KM; Lewis JA
    Stat Med; 1998 Aug 15-30; 17(15-16):1801-9; discussion 1811-2. PubMed ID: 9749448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating health promotion: a tale of three errors.
    Tones K
    Patient Educ Couns; 2000 Feb; 39(2-3):227-36. PubMed ID: 11040722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality assurance of data collection in the multi-site community randomized trial and prevalence survey of the children's healthy living program.
    Yamanaka A; Fialkowski MK; Wilkens L; Li F; Ettienne R; Fleming T; Power J; Deenik J; Coleman P; Leon Guerrero R; Novotny R
    BMC Res Notes; 2016 Sep; 9(1):432. PubMed ID: 27590179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behind closed doors: the data monitoring board in randomized clinical trials.
    Wittes J
    Stat Med; 1993 Mar; 12(5-6):419-24. PubMed ID: 8493420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost data for individual patients included in clinical studies: no amount of statistical analysis can compensate for inadequate costing methods.
    Graves N; Walker D; Raine R; Hutchings A; Roberts JA
    Health Econ; 2002 Dec; 11(8):735-9. PubMed ID: 12457373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Good intentions and ICH-GCP: Trial conduct training needs to go beyond the ICH-GCP document and include the intention-to-treat principle.
    Browne LH; Graham PH
    Clin Trials; 2014 Dec; 11(6):629-34. PubMed ID: 25023199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mega-trials: methodological issues and clinical implications.
    Charlton BG
    J R Coll Physicians Lond; 1995; 29(2):96-100. PubMed ID: 7595900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation and results of an integrated data quality assurance protocol in a randomized controlled trial in Uttar Pradesh, India.
    Gass JD; Misra A; Yadav MNS; Sana F; Singh C; Mankar A; Neal BJ; Fisher-Bowman J; Maisonneuve J; Delaney MM; Kumar K; Singh VP; Sharma N; Gawande A; Semrau K; Hirschhorn LR
    Trials; 2017 Sep; 18(1):418. PubMed ID: 28882167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Data monitoring committees for pragmatic clinical trials.
    Ellenberg SS; Culbertson R; Gillen DL; Goodman S; Schrandt S; Zirkle M
    Clin Trials; 2015 Oct; 12(5):530-6. PubMed ID: 26374679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The revised CONSORT statement: honing the cutting edge of the randomized controlled trial.
    Shapiro S
    CMAJ; 2001 Apr; 164(8):1157-8. PubMed ID: 11338802
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.